Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Date | Company Name | Round | Money Raised | Industry | |
---|---|---|---|---|---|
Jun 22, 2021 |
![]() |
Series A | $51M | Biotechnology | Detail |
Aug 11, 2020 |
![]() |
Seed | $4.90M | Biotechnology | Detail |